Why a promising ALS drug failed—despite hitting its target
A new Emory University study, led by the Emory ALS Center and the Center for Neurodegenerative Disease at Emory's Goizueta Brain Health Institute, sheds light on why a once-promising experimental medication for amyotrophic ...
Sep 9, 2025
0
20









